Combined endocrine therapy for breast cancer - New life for an old idea?

被引：12

作者：

Davidson, NE ^{[1
]}

机构：

[1] Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2000年 / 92卷 / 11期

关键词：

D O I：

10.1093/jnci/92.11.859

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：859 / 860

页数：2

共 15 条

[1]

BARTLETT K, 1993, LANCET, V341, P1293

[2] CHEMOTHERAPY VERSUS TAMOXIFEN VERSUS CHEMOTHERAPY PLUS TAMOXIFEN IN NODE-POSITIVE, ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER PATIENTS - AN UPDATE AT 7 YEARS OF THE 1ST GROCTA (BREAST-CANCER-ADJUVANT-CHEMO-HORMONE-THERAPY-COOPERATIVE-GROUP) TRIAL [J].

BOCCARDO, F ;

RUBAGOTTI, A ;

AMOROSO, D ;

SISMONDI, P ;

GENTA, F ;

NENCI, I ;

PIFFANELLI, A ;

FARRIS, A ;

CASTAGNETTA, L ;

TRAINA, A ;

CAPPELLINI, M ;

PACINI, P ;

SASSI, M ;

MALACARNE, P ;

DONATI, D ;

MUSTACCHI, G ;

GALLETTO, L ;

SCHIEPPATI, G ;

VILLA, E ;

BOLOGNESI, A ;

GALLO, L .

EUROPEAN JOURNAL OF CANCER, 1992, 28A (2-3) :673-680

[3]

BOCCARDO F, 1998, P AN M AM SOC CLIN, V17, pA99

[4]

Clarke M, 1996, LANCET, V348, P1189

[5]

Clarke M, 1998, LANCET, V351, P1451

[6]

DAVIDSON N, 1999, P AN M AM SOC CLIN, V18, pA67

[7]

Ejlertsen B, 1999, P AN M AM SOC CLIN, V18, P66

[8] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].

Fisher, B ;

Costantino, JP ;

Wickerham, DL ;

Redmond, CK ;

Kavanah, M ;

Cronin, WM ;

Vogel, V ;

Robidoux, A ;

Dimitrov, N ;

Atkins, J ;

Daly, M ;

Wieand, S ;

Tan-Chiu, E ;

Ford, L ;

Wolmark, N .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388

[9]

JAKESZ R, 1999, P AN M AM SOC CLIN, V18, pA67

[10] Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: A randomized study [J].

Klijn, JGM ;

Beex, LVAM ;

Mauriac, L ;

van Zijl, JA ;

Veyret, C ;

Wildiers, J ;

Jassem, J ;

Piccart, M ;

Burghouts, J ;

Becquart, D ;

Seynaeve, C ;

Mignolet, F ;

Duchateau, L .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (11) :903-911

← 1 2 →